City Therapeutics, Inc. (CTY)
NASDAQ
CTY price, last 12 months
Key stats
- Previous close
- $16.64
- Open
- $16.75
- Day range
- $16.75 – $18.59
- 52-week range
- $15.81 – $23.88
- Volume
- 245.9K
- Avg volume (20 days)
- 277.4K
- Market cap
- $911.0M
Performance
Technicals and fundamentals
About City Therapeutics, Inc.
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.
- Listed on
- NASDAQ
- Market cap
- $911.0M